Decision looms that could determine fate of Alzheimer's drug
Decision looms that could determine fate of Alzheimer’s drug
Stay updated with breaking news from Memory Disorders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Decision looms that could determine fate of Alzheimer’s drug
Medicare officials are trying to determine whether to cover Aduhelm, which the F.D.A. approved despite unclear evidence that it helps patients.
A study released Monday concluded that a self-administered test detected signs of potential dementia, including Alzheimer’s disease, at least six months ahead of the standard testing method, suggesting the exam may
A world-renowned clinician-researcher has joined the Schmidt College of Medicine to direct the FAU Center for Brain Health to focus on Alzheimer’s disease and neurodegenerative dementia prevention.
Sosiaali- ja terveysalan sadat eri järjestöt etsivät paikkaansa uudessa aluehallinnossa. Etelä-Pohjanmaalla siihen on ollut hyvä mahdollisuus, sillä järjestöt on otettu valmisteluun mukaan alusta lähtien.